Loss of fertility from gonadotoxic treatments is a long-term affect in a growing cohort of patients. While post-pubertal patients have the option of oocyte/embryo cryopreservation, pre-pubertal patients only option is ovarian tissue cryopreservation (OTC). While several studies have established the feasibility of pre-pubertal OTC, we seek to examine any differences in tissue or oocytes collection between pre and post-pubertal patients.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Pediatric and Adolescent Gynecology
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect